Skip to Content

Ph1/2 FIH MRTX1719 ST MTAP Deletion

Phase I/II Clinical Trial

A Phase 1 Multiple Expansion Cohort Trial of MRTX1719 (BMS-986504) in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion (1719-001/CA240-0007)

Indication: Pancreatic Cancer, Pancreatic Cancer, Pancreatic Cancer, Pancreatic Cancer, Pancreatic Cancer
Trial Number: 05245500
Trial Status: Call Proj Mgr

Participating Locations